Detection and quantification of residual disease in chronic myelogenous leukemia

A Hochhaus, A Weisser, P La Rosee, M Emig… - Leukemia, 2000 - nature.com
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the 'gold …
被引用次数：152 相关文章
[PDF] researchgate.net

[PDF][PDF] Detection and quantification of residual disease in chronic myelogenous leukemia

A Hochhaus, A Weisser, P La Rosée, M Emig… - Leukemia, 2000 - researchgate.net
Chronic myelogenous leukemia (CML) constitutes a clinical model for molecular detection
and therapy surveillance of malignant disease since this entity was the first leukemia shown …

[引用][C] Detection and quantification of residual disease in chronic myelogenous leukemia

A HOCHHAUS, A WEISSER, N CROSSE… - …, 2000 - pascal-francis.inist.fr
Detection and quantification of residual disease in chronic myelogenous leukemia CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Detection and quantification of residual disease in chronic myelogenous leukemia.

A Hochhaus, A Weisser, P La Rosée… - Leukemia …, 2000 - search.ebscohost.com
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the'gold …

Detection and quantification of residual disease in chronic myelogenous leukemia

A Hochhaus, A Weisser, P La Rosée, M Emig… - …, 2000 - pubmed.ncbi.nlm.nih.gov
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the'gold …

Detection and quantification of residual disease in chronic myelogenous leukemia

A Hochhaus, A Weisser, P La Rosee, M Emig… - Leukemia, 2000 - go.gale.com
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the'gold …

Detection and quantification of residual disease in chronic myelogenous leukemia.

A Hochhaus, A Weisser, P La Rosée, M Emig… - Leukemia, 2000 - europepmc.org
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the'gold …

[引用][C] Detection and quantification of residual disease in chronic myelogenous leukemia

A HOCHHAUS, A WEISSER, P LA ROSEE… - …, 2000 - Nature Publishing Group

[引用][C] Detection and quantification of residual disease in chronic myelogenous leukemia

A Hochhaus, A Weisser, P La Rosée, M Emig… - …, 2000 - Nature Publishing Group